| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |